Comprehensive analysis of single-cell and bulk RNA sequencing reveals postoperative progression markers for non-muscle invasive bladder cancer and predicts responses to immunotherapy
AURKB, GINS2, and UHRF1 have the potential to enhance postoperative management of NMIBC patients undergoing transurethral resection of bladder tumor (TURBT) and can predict immunotherapy response, establishing them as promising therapeutic targets.
Authors
- Zhiliang Xiao
- Yuan Wang (ORCID: https://orcid.org/0000-0003-1575-4596)
- Sicong Jiang (ORCID: https://orcid.org/0000-0001-8974-6770)
- Xin Liu (ORCID: https://orcid.org/0000-0002-5646-423X)
- Yan Feng
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1007/s12672-024-01548-2
- Citations
- 7
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01